Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 290.00
Bid: 294.00
Ask: 295.50
Change: 0.50 (0.17%)
Spread: 1.50 (0.51%)
Open: 298.00
High: 298.00
Low: 284.50
Prev. Close: 289.50
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PROPOSED OFFERING OF EUR300M BOND & REFINANCING

25 Jun 2018 07:19

RNS Number : 3615S
Synthomer PLC
25 June 2018
 

25.06.18

PROPOSED OFFERING OF €300M BOND & REFINANCING

Synthomer plc ('Synthomer' or 'the Group'), is pleased to announce a refinancing of its existing bank facilities (the "Refinancing") consisting of an offering (the "Offering") of a €300m seven-year unsecured senior notes (the "Notes") and a new €300 million four-year revolving credit facility ("RCF").

The proceeds of the issue and sale of the Notes will be used, together with cash on hand and borrowings under the new revolving credit facility, to: (i) repay all amounts outstanding under our existing revolving credit facility; (ii) repay amounts outstanding under our existing term loan; and (iii) pay certain costs, expenses and fees related to the Refinancing.

The proposed Refinancing will strengthen the Group's financial position through increased financial flexibility, providing an appropriate capital structure and allowing it to secure, in relation to the Notes, an attractive fixed interest rate for the next seven years. The Group's strategy for further continued profitable growth is expected to be supported with this efficient capital structure.

Commenting on the Refinancing, Stephen Bennett, CFO, said:

"This Refinancing is being undertaken ahead of the maturity of our current facilities and aims to achieve favourable terms in both the bond and bank markets. This new broader capital structure will allow the Group more flexibility to deliver on its strategy of building sustainable growth".

There will be no public offering of the Notes. The Notes are being offered and sold in offshore transactions outside the United States in compliance with Regulation S under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"). The Notes may not be offered, sold or delivered within the United States (as defined in Regulation S under the U.S. Securities Act), except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act.

 

ENQUIRIES:

Stephen Bennett, Chief Financial Officer

Tel: 01279 436211

Charles Armitstead / Rosie Oddy, Teneo Blue Rubicon

Tel: 020 3603 5220

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFAMFTMBMTMRP
Date   Source Headline
7th Jun 20124:35 pmRNSDirector/PDMR Shareholding
25th May 201211:00 amRNSDirector Declaration
17th May 201212:22 pmRNSResult of AGM
17th May 201211:00 amRNSDirectorate Change
17th May 20127:00 amRNSInterim Management Statement
14th May 20123:47 pmRNSAnnual Information Update
17th Apr 20129:18 amRNSAnnual Financial Report
3rd Apr 20123:11 pmRNSDirector/PDMR Shareholding
2nd Apr 20127:00 amRNSMarl Site Operations
28th Mar 20125:15 pmRNSHolding(s) in Company
26th Mar 20127:00 amRNSDirector/PDMR Shareholding
23rd Mar 20127:00 amRNSDirectorate Change
19th Mar 20124:10 pmRNSDirector/PDMR Shareholding
16th Mar 20121:48 pmRNSDirector/PDMR Shareholding
16th Mar 20121:46 pmRNSDirector/PDMR Shareholding
16th Mar 20121:09 pmRNSDirector/PDMR Shareholding
14th Mar 20123:52 pmRNSDirector/PDMR Shareholding
14th Mar 20127:00 amRNSFinal Results
11th Jan 20127:00 amRNSTrading Update
9th Jan 201210:24 amRNSDirector/PDMR Shareholding
3rd Jan 20124:51 pmRNSDirector/PDMR Shareholding
1st Dec 20117:00 amRNSDisposal of Pharma Division
25th Nov 20117:00 amRNSDirectorate Change
10th Nov 20117:00 amRNSInterim Management Statement
1st Nov 20113:33 pmRNSHolding(s) in Company
31st Oct 201110:15 amRNSHolding(s) in Company
20th Oct 20112:42 pmRNSHolding(s) in Company
17th Oct 20118:20 amRNSAcquisition
28th Sep 20117:00 amRNSAnalyst and Investor Site Visit
5th Sep 20117:00 amRNSAppointment of Joint Broker
26th Aug 20117:00 amRNSHalf Yearly Report
10th Aug 20118:58 amRNSHolding(s) in Company
4th Aug 20119:02 amRNSBoard appointment
27th Jul 20111:12 pmRNSHolding(s) in Company
29th Jun 20114:46 pmRNSDirector/PDMR Shareholding
29th Jun 20114:44 pmRNSDirector/PDMR Shareholding
29th Jun 20112:17 pmRNSResult of EGM
22nd Jun 20113:59 pmRNSHolding(s) in Company
16th Jun 20114:39 pmRNSHolding(s) in Company
16th Jun 20114:37 pmRNSHolding(s) in Company
13th Jun 201111:14 amRNSNotice of EGM
9th Jun 201110:44 amRNSHolding(s) in Company
12th May 20113:51 pmRNSResult of AGM
12th May 20117:00 amRNSInterim Management Statement
4th May 20113:17 pmRNSAnnual Information Update
3rd May 20111:30 pmRNSHolding(s) in Company
28th Apr 201112:28 pmRNSHolding(s) in Company
21st Apr 20113:24 pmRNSDirector/PDMR Shareholding
21st Apr 20113:19 pmRNSDirector/PDMR Shareholding
7th Apr 20113:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.